Predictors of perioperative morbidity and mortality in lung volume reduction surgery

被引:16
作者
Glaspole, IN
Gabbay, E
Smith, JA
Rabinov, M
Snell, GI
机构
[1] Alfred Hosp, Dept Resp Med, Prahran, Vic 3181, Australia
[2] Alfred Hosp, Dept Thorac Surg, Prahran, Vic 3181, Australia
关键词
D O I
10.1016/S0003-4975(00)01270-4
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background. Selection criteria for lung volume reduction surgery are still being refined. We sought to determine whether preoperative features could be used to predict early morbidity or mortality. Methods. We reviewed preoperative characteristics of the first 89 patients who underwent lung volume reduction surgery at the Alfred Hospital. Data included arterial blood gases, prednisolone use, pulmonary function tests, 6-minute walk test, and anesthetic time. Length of stay and reintubation for respiratory failure were used as markers of morbidity. Results. Findings included Pace, of 43 +/- 0.7 mm Hg, Pao, 70 +/- 1.1 mm Hg, percent predicted values for forced expiratory volume in 1 second 29.6% +/- 0.8%, TLCO% predicted 35.2 +/- 1.4%, and 6-minute walk test of 315 +/- 10.6 m (mean +/- SEM). Mean length of stay was 19 +/- 2 days, with 17 (19%) patients reintubated for respiratory failure. Mortality rate was 5.6% at 1 year post surgery, with no deaths in patients less than 65 years old. Multivariate analysis revealed that length of stay, reintubation and mortality were predicted by age and surgical time (p < 0.05), with no correlation with any other variables tested. Age greater than 70 years was associated with a significant risk of mortality (OR 9.0; p = 0.04). Conclusions. Age greater than 70 years and anesthetic time greater than 210 minutes predict both perioperative morbidity and mortality. (C) 2000 by The Society of Thoracic Surgeons.
引用
收藏
页码:1711 / 1716
页数:6
相关论文
共 20 条
[1]
[Anonymous], AUSTR HLTH 1998 6 BI
[2]
[Anonymous], AM J MED S3B, DOI DOI 10.1016/0002-9343(91)90361-Z
[3]
*AUSTR I HLTH WELF, HLTH SERV SER, V11
[4]
Anaesthesia and postoperative pain management for bilateral lung volume reduction surgery [J].
Buettner, AU ;
McRae, R ;
Myles, PS ;
Snell, GI ;
Bujor, MA ;
Silvers, A ;
Weeks, AM .
ANAESTHESIA AND INTENSIVE CARE, 1999, 27 (05) :503-508
[5]
Current thoughts regarding treatment of chronic obstructive pulmonary disease [J].
Celli, BR .
MEDICAL CLINICS OF NORTH AMERICA, 1996, 80 (03) :589-+
[6]
Chatila W, 1999, AM J RESP CRIT CARE, V159, pA925
[7]
BILATERAL PNEUMECTOMY (VOLUME REDUCTION) FOR CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
COOPER, JD ;
TRULOCK, EP ;
TRIANTAFILLOU, AN ;
PATTERSON, GA ;
POHL, MS ;
DELONEY, PA ;
SUNDARESAN, RS ;
ROPER, CL .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (01) :106-119
[8]
Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema [J].
Cooper, JD ;
Patterson, GA ;
Sundaresan, RS ;
Trulock, EP ;
Yusen, RD ;
Pohl, MS ;
Lefrak, SS .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (05) :1319-1329
[9]
Stability of improvements in exercise performance and quality of life following bilateral lung volume reduction surgery in severe COPD [J].
Cordova, F ;
OBrien, G ;
Furukawa, S ;
Kuzma, AM ;
Travaline, J ;
Criner, GJ .
CHEST, 1997, 112 (04) :907-915
[10]
PREOPERATIVE PULMONARY-FUNCTION TESTING TO PREDICT POSTOPERATIVE MORBIDITY AND MORTALITY [J].
GASS, GD ;
OLSEN, GN .
CHEST, 1986, 89 (01) :127-135